In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival

RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease

(2015) Kilian M. Gust et al.   NEOPLASIA

Filling the mosaic of p53 actions: p53 represses RHAMM expression

(2011) Samuel Godar et al.   CELL CYCLE

Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia

(2010) Ellen Christina Obermann et al.   ANNALS OF HEMATOLOGY

RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53

(2010) Sindy Sohr et al.   CELL CYCLE

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores

(2010) Alexandar Tzankov et al.   LEUKEMIA & LYMPHOMA

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

(2009) C. M. Santamaria et al.   BLOOD

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study

(2009) Anders Wahlin et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas

(2009) Sabine Nagel et al.   EXPERIMENTAL HEMATOLOGY

The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses

(2009) Schmitt   INTERNATIONAL JOURNAL OF ONCOLOGY

Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas

(2009) Shigeishi   INTERNATIONAL JOURNAL OF ONCOLOGY

Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis

(2009) K. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells

(2008) J. Greiner et al.   CLINICAL CANCER RESEARCH

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer

(2008) I Zlobec et al.   GUT

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?

(2008) C. A. Maxwell et al.   JOURNAL OF CELL SCIENCE

The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia

(2008) K Giannopoulos et al.   LEUKEMIA

Diagnosis and Prognosis in Acute Myeloid Leukemia — The Art of Distinction

(2008) Bob Löwenberg   NEW ENGLAND JOURNAL OF MEDICINE